Filing Details
- Accession Number:
- 0001209191-23-007575
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2023-02-07 16:53:40
- Reporting Period:
- 2022-12-31
- Accepted Time:
- 2023-02-07 16:53:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1641281 | Bolt Biotherapeutics Inc. | BOLT | () | 5 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1604763 | C Randall Schatzman | C/O Bolt Biotherapeutics, Inc. 900 Chesapeake Drive Redwood City CA 94063 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-06 | 2,500 | $1.64 | 5,359 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2022-12-06 | 2,500 | $1.18 | 7,859 | No | 5 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | P | Direct | |
No | 5 | P | Direct |
Footnotes
- Shares acquired under the issuer's Employee Stock Purchase Plan.